Concepedia

Amy Hirsch Shumaker

AH

Statistics

Publications

6

Citations

1.3K

H-Index

6

Active since

2015

Affiliations

University School(Current)

Case Western Reserve University

McMaster University

Queen Mary Hospital

University of Hong Kong

Amy Hirsch Shumaker is an author at University School specializing in infectious diseases, treatment of coronavirus infections, and pharmacy.

Publications per year

2015–2024

6

Publications

6

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)

Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker et al. · Clinical Infectious Diseases · 2020 · 1.1K citations · Full text

, , +12

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)

Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker et al. · Clinical Infectious Diseases · 2022 · 201 citations · Full text

, , +12

Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel

Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker et al. · Clinical Infectious Diseases · 2021 · 20 citations · Full text

, , +11

Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords

Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker et al. · Clinical Infectious Diseases · 2021 · 15 citations · Full text

, , +12

2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis

Adarsh Bhimraj, Yngve Falck–Ytter, Arthur Y Kim et al. · Clinical Infectious Diseases · 2024 · 14 citations · Full text

, , +14

1–5 of 6